0001236215-21-000011.txt : 20211129
0001236215-21-000011.hdr.sgml : 20211129
20211129091741
ACCESSION NUMBER: 0001236215-21-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211119
FILED AS OF DATE: 20211129
DATE AS OF CHANGE: 20211129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERSTEN GEERT R
CENTRAL INDEX KEY: 0001236030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 211453128
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD
STREET 2: STE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-11-19
0
0000725363
CEL SCI CORP
CVM
0001236030
KERSTEN GEERT R
8229 BOONE BLVD
STE 802
VIENNA
VA
22182
1
1
0
0
Chief Executive Officer
Options
10.48
2021-11-19
4
A
0
50000
0.01
A
2031-11-18
Common Stock
50000
3781909
D
Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022.
Geert Kersten
2021-11-29